Dynamic Bayesian networks for prediction of health status and treatment effect in patients with chronic lymphocytic leukemia
Abstract Chronic lymphocytic leukemia (CLL) is the most common blood cancer in adults. The course of CLL and patients' response to treatment are varied. This variability makes it difficult to select the most appropriate treatment regimen and predict the progression of the disease. This work was...
Main Authors: | Piotr Ladyzynski, Maria Molik, Piotr Foltynski |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-05813-8 |
Similar Items
-
The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions
by: Tadeusz Robak, et al.
Published: (2022-02-01) -
Atypical Chronic Lymphocytic Leukemia—The Current Status
by: Tadeusz Robak, et al.
Published: (2023-09-01) -
Alemtuzumab in treatment of chronic lymphocytic leukemia
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01) -
Predicting the overall survival of patients with chronic lymphocytic leukemia in the dynamics of the disease
by: M. V. Markovtseva, et al.
Published: (2023-10-01) -
A personalized stepwise dynamic predictive algorithm of the time to first treatment in chronic lymphocytic leukemia
by: Theodoros Moysiadis, et al.
Published: (2023-09-01)